カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

膀胱がんの世界市場2022：膀胱内治療、化学療法、保存療法

■ 英語タイトル：Global Bladder Cancer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3292）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3292
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[膀胱がんの世界市場2022：膀胱内治療、化学療法、保存療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の膀胱がん市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の膀胱がんの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

膀胱がん市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・膀胱内治療、化学療法、保存療法

アプリケーション別セグメントは次のように区分されます。
・病院、診療所

世界の膀胱がん市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、Eli Lilly、F. Hoffman-La Roche、Pfizer、Accord Healthcare、AstraZeneca、Bedford Lab、Merck、Sanofi

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、膀胱がん製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な膀胱がんメーカーの企業概要、2019年～2022年までの膀胱がんの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な膀胱がんメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別膀胱がんの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの膀胱がんの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での膀胱がん市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および膀胱がんの産業チェーンを掲載しています。
・第13、14、15章では、膀胱がんの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 膀胱がんの概要
– 種類別分析（2017年vs2021年vs2028年）：膀胱内治療、化学療法、保存療法
– 用途別分析（2017年vs2021年vs2028年）：病院、診療所
– 世界の膀胱がん市場規模・予測
– 世界の膀胱がん生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bristol-Myers Squibb、Eli Lilly、F. Hoffman-La Roche、Pfizer、Accord Healthcare、AstraZeneca、Bedford Lab、Merck、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：膀胱内治療、化学療法、保存療法
・用途別分析2017年-2028年：病院、診療所
・膀胱がんの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・膀胱がんのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・膀胱がんのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・膀胱がんの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・膀胱がんの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Bladder Cancer Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bladder Cancer Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravesical therapy
1.2.3 Chemotherapy
1.2.4 Preservation therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Bladder Cancer Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Bladder Cancer Market Size & Forecast
1.4.1 Global Bladder Cancer Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bladder Cancer Sales in Volume (2017-2028)
1.4.3 Global Bladder Cancer Price (2017-2028)
1.5 Global Bladder Cancer Production Capacity Analysis
1.5.1 Global Bladder Cancer Total Production Capacity (2017-2028)
1.5.2 Global Bladder Cancer Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bladder Cancer Market Drivers
1.6.2 Bladder Cancer Market Restraints
1.6.3 Bladder Cancer Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Bladder Cancer Product and Services
2.1.4 Bristol-Myers Squibb Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Bladder Cancer Product and Services
2.2.4 Eli Lilly Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 F. Hoffman-La Roche
2.3.1 F. Hoffman-La Roche Details
2.3.2 F. Hoffman-La Roche Major Business
2.3.3 F. Hoffman-La Roche Bladder Cancer Product and Services
2.3.4 F. Hoffman-La Roche Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Bladder Cancer Product and Services
2.4.4 Pfizer Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Accord Healthcare
2.5.1 Accord Healthcare Details
2.5.2 Accord Healthcare Major Business
2.5.3 Accord Healthcare Bladder Cancer Product and Services
2.5.4 Accord Healthcare Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Bladder Cancer Product and Services
2.6.4 AstraZeneca Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bedford Lab
2.7.1 Bedford Lab Details
2.7.2 Bedford Lab Major Business
2.7.3 Bedford Lab Bladder Cancer Product and Services
2.7.4 Bedford Lab Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Bladder Cancer Product and Services
2.8.4 Merck Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Bladder Cancer Product and Services
2.9.4 Sanofi Bladder Cancer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bladder Cancer Breakdown Data by Manufacturer
3.1 Global Bladder Cancer Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bladder Cancer Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bladder Cancer
3.4 Market Concentration Rate
3.4.1 Top 3 Bladder Cancer Manufacturer Market Share in 2021
3.4.2 Top 6 Bladder Cancer Manufacturer Market Share in 2021
3.5 Global Bladder Cancer Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bladder Cancer Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bladder Cancer Market Size by Region
4.1.1 Global Bladder Cancer Sales in Volume by Region (2017-2028)
4.1.2 Global Bladder Cancer Revenue by Region (2017-2028)
4.2 North America Bladder Cancer Revenue (2017-2028)
4.3 Europe Bladder Cancer Revenue (2017-2028)
4.4 Asia-Pacific Bladder Cancer Revenue (2017-2028)
4.5 South America Bladder Cancer Revenue (2017-2028)
4.6 Middle East and Africa Bladder Cancer Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bladder Cancer Sales in Volume by Type (2017-2028)
5.2 Global Bladder Cancer Revenue by Type (2017-2028)
5.3 Global Bladder Cancer Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bladder Cancer Sales in Volume by Application (2017-2028)
6.2 Global Bladder Cancer Revenue by Application (2017-2028)
6.3 Global Bladder Cancer Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bladder Cancer Sales by Type (2017-2028)
7.2 North America Bladder Cancer Sales by Application (2017-2028)
7.3 North America Bladder Cancer Market Size by Country
7.3.1 North America Bladder Cancer Sales in Volume by Country (2017-2028)
7.3.2 North America Bladder Cancer Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bladder Cancer Sales by Type (2017-2028)
8.2 Europe Bladder Cancer Sales by Application (2017-2028)
8.3 Europe Bladder Cancer Market Size by Country
8.3.1 Europe Bladder Cancer Sales in Volume by Country (2017-2028)
8.3.2 Europe Bladder Cancer Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bladder Cancer Sales by Type (2017-2028)
9.2 Asia-Pacific Bladder Cancer Sales by Application (2017-2028)
9.3 Asia-Pacific Bladder Cancer Market Size by Region
9.3.1 Asia-Pacific Bladder Cancer Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bladder Cancer Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bladder Cancer Sales by Type (2017-2028)
10.2 South America Bladder Cancer Sales by Application (2017-2028)
10.3 South America Bladder Cancer Market Size by Country
10.3.1 South America Bladder Cancer Sales in Volume by Country (2017-2028)
10.3.2 South America Bladder Cancer Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bladder Cancer Sales by Type (2017-2028)
11.2 Middle East & Africa Bladder Cancer Sales by Application (2017-2028)
11.3 Middle East & Africa Bladder Cancer Market Size by Country
11.3.1 Middle East & Africa Bladder Cancer Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bladder Cancer Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bladder Cancer and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bladder Cancer
12.3 Bladder Cancer Production Process
12.4 Bladder Cancer Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bladder Cancer Typical Distributors
13.3 Bladder Cancer Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Bladder Cancer Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bladder Cancer Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Bladder Cancer Product and Services
Table 6. Bristol-Myers Squibb Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Bladder Cancer Product and Services
Table 10. Eli Lilly Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table 12. F. Hoffman-La Roche Major Business
Table 13. F. Hoffman-La Roche Bladder Cancer Product and Services
Table 14. F. Hoffman-La Roche Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Bladder Cancer Product and Services
Table 18. Pfizer Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Accord Healthcare Major Business
Table 21. Accord Healthcare Bladder Cancer Product and Services
Table 22. Accord Healthcare Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Bladder Cancer Product and Services
Table 26. AstraZeneca Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bedford Lab Basic Information, Manufacturing Base and Competitors
Table 28. Bedford Lab Major Business
Table 29. Bedford Lab Bladder Cancer Product and Services
Table 30. Bedford Lab Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Bladder Cancer Product and Services
Table 34. Merck Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Bladder Cancer Product and Services
Table 38. Sanofi Bladder Cancer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Bladder Cancer Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Bladder Cancer Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Bladder Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Bladder Cancer Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Bladder Cancer Production Site of Key Manufacturer
Table 44. Bladder Cancer New Entrant and Capacity Expansion Plans
Table 45. Bladder Cancer Mergers & Acquisitions in the Past Five Years
Table 46. Global Bladder Cancer Sales by Region (2017-2022) & (K Units)
Table 47. Global Bladder Cancer Sales by Region (2023-2028) & (K Units)
Table 48. Global Bladder Cancer Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Bladder Cancer Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 51. Global Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 52. Global Bladder Cancer Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Bladder Cancer Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Bladder Cancer Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Bladder Cancer Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 57. Global Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 58. Global Bladder Cancer Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Bladder Cancer Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Bladder Cancer Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Bladder Cancer Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Bladder Cancer Sales by Country (2017-2022) & (K Units)
Table 63. North America Bladder Cancer Sales by Country (2023-2028) & (K Units)
Table 64. North America Bladder Cancer Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Bladder Cancer Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 67. North America Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 68. North America Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 69. North America Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 70. Europe Bladder Cancer Sales by Country (2017-2022) & (K Units)
Table 71. Europe Bladder Cancer Sales by Country (2023-2028) & (K Units)
Table 72. Europe Bladder Cancer Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Bladder Cancer Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 75. Europe Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 76. Europe Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 77. Europe Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Bladder Cancer Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Bladder Cancer Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Bladder Cancer Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Bladder Cancer Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 86. South America Bladder Cancer Sales by Country (2017-2022) & (K Units)
Table 87. South America Bladder Cancer Sales by Country (2023-2028) & (K Units)
Table 88. South America Bladder Cancer Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Bladder Cancer Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 91. South America Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 92. South America Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 93. South America Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Bladder Cancer Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Bladder Cancer Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Bladder Cancer Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Bladder Cancer Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Bladder Cancer Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Bladder Cancer Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Bladder Cancer Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Bladder Cancer Sales by Application (2023-2028) & (K Units)
Table 102. Bladder Cancer Raw Material
Table 103. Key Manufacturers of Bladder Cancer Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Bladder Cancer Typical Distributors
Table 107. Bladder Cancer Typical Customers
List of Figures
Figure 1. Bladder Cancer Picture
Figure 2. Global Bladder Cancer Revenue Market Share by Type in 2021
Figure 3. Intravesical therapy
Figure 4. Chemotherapy
Figure 5. Preservation therapy
Figure 6. Global Bladder Cancer Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Global Bladder Cancer Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Bladder Cancer Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Bladder Cancer Sales (2017-2028) & (K Units)
Figure 12. Global Bladder Cancer Price (2017-2028) & (US$/Unit)
Figure 13. Global Bladder Cancer Production Capacity (2017-2028) & (K Units)
Figure 14. Global Bladder Cancer Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Bladder Cancer Market Drivers
Figure 16. Bladder Cancer Market Restraints
Figure 17. Bladder Cancer Market Trends
Figure 18. Global Bladder Cancer Sales Market Share by Manufacturer in 2021
Figure 19. Global Bladder Cancer Revenue Market Share by Manufacturer in 2021
Figure 20. Bladder Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Bladder Cancer Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Bladder Cancer Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Bladder Cancer Sales Market Share by Region (2017-2028)
Figure 24. Global Bladder Cancer Revenue Market Share by Region (2017-2028)
Figure 25. North America Bladder Cancer Revenue (2017-2028) & (USD Million)
Figure 26. Europe Bladder Cancer Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Bladder Cancer Revenue (2017-2028) & (USD Million)
Figure 28. South America Bladder Cancer Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Bladder Cancer Revenue (2017-2028) & (USD Million)
Figure 30. Global Bladder Cancer Sales Market Share by Type (2017-2028)
Figure 31. Global Bladder Cancer Revenue Market Share by Type (2017-2028)
Figure 32. Global Bladder Cancer Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 34. Global Bladder Cancer Revenue Market Share by Application (2017-2028)
Figure 35. Global Bladder Cancer Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Bladder Cancer Sales Market Share by Type (2017-2028)
Figure 37. North America Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 38. North America Bladder Cancer Sales Market Share by Country (2017-2028)
Figure 39. North America Bladder Cancer Revenue Market Share by Country (2017-2028)
Figure 40. United States Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Bladder Cancer Sales Market Share by Type (2017-2028)
Figure 44. Europe Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 45. Europe Bladder Cancer Sales Market Share by Country (2017-2028)
Figure 46. Europe Bladder Cancer Revenue Market Share by Country (2017-2028)
Figure 47. Germany Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Bladder Cancer Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Bladder Cancer Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Bladder Cancer Revenue Market Share by Region (2017-2028)
Figure 56. China Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Bladder Cancer Sales Market Share by Type (2017-2028)
Figure 63. South America Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 64. South America Bladder Cancer Sales Market Share by Country (2017-2028)
Figure 65. South America Bladder Cancer Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Bladder Cancer Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Bladder Cancer Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Bladder Cancer Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Bladder Cancer Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Bladder Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Bladder Cancer in 2021
Figure 77. Manufacturing Process Analysis of Bladder Cancer
Figure 78. Bladder Cancer Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 抗がん剤の世界市場2022：化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他
  • 上咽頭がんのグローバル市場（2022年-2029年）：化学療法、免疫療法、放射線療法、その他
  • 甲状腺乳頭癌治療のグローバル市場2023：手術、ヨード治療、サイロキシン治療、化学療法、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3292 )"膀胱がんの世界市場2022：膀胱内治療、化学療法、保存療法" (英文：Global Bladder Cancer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。